Effects of Including a Chronic Pain Neuroscience Education Program for Individuals With Knee OA
1 other identifier
interventional
88
1 country
1
Brief Summary
Research participants diagnosed with knee osteoarthritis will be randomized through a draw using sealed opaque envelopes indicating two groups: 1. therapeutic exercises, 2. therapeutic exercises + chronic pain neuroscience education program. The primary outcome will be functional performance using a patient-reported measure, the Knee Injury and Osteoarthritis Outcome Score (KOOS). The selected secondary outcomes will be pain intensity by the numerical pain scale (END), physical function reported by the patient by the patient-specific functional scale (EFEP), Pain self-efficacy questionnaire (PSEQ), functional mobility by the timed up and test (TUG), general effect perceived through the global perception scale (EPG), muscle strength through Maximum Voluntary Isometric Contraction (MVIC) and functionality and disability through the World Health Organization Disability Assessment Schedule (WHODAS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 15, 2023
CompletedFirst Posted
Study publicly available on registry
January 2, 2024
CompletedStudy Start
First participant enrolled
May 28, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 15, 2026
March 20, 2026
March 1, 2026
2.5 years
December 15, 2023
March 17, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Functional disability
Knee Injury and Osteoarthritis Outcome Score (KOOS). It aims to evaluate the domains of pain, symptoms, activities of daily living, function related to recreation and sports, and quality of life related to the knee. Totaling 42 items, each item must be answered using a Likert scale that ranges from 0 (best score) to 4 (worst score), and the score for each subscale ranges from 0 (worst score) to 100 (best score).
Change from Baseline, after 10 weeks of intervention and 4 weeks after the end of the intervention.
Secondary Outcomes (7)
Numerical Pain Scale
Change from Baseline, after 10 weeks of intervention and 4 weeks after the end of the intervention.
Functional self-perception
Change from Baseline, after 10 weeks of intervention and 4 weeks after the end of the intervention.
Self-perceived functionality
Change from Baseline, after 10 weeks of intervention and 4 weeks after the end of the intervention.
Maximum voluntary isometric contraction
Change from Baseline, after 10 weeks of intervention and 4 weeks after the end of the intervention.
Dynamic balance
Change from Baseline, after 10 weeks of intervention and 4 weeks after the end of the intervention.
- +2 more secondary outcomes
Study Arms (2)
Therapeutic exercise group
ACTIVE COMPARATORThe therapeutic exercise program will include warm-up, resistance, neuromuscular, mobility, and balance exercises. Over ten weeks, two sessions of the therapeutic exercise program will be carried out individually, lasting approximately 60 minutes each-a total of 20 therapeutic exercise sessions. Therapeutic exercise sessions will be carried out at least 24 hours between sessions. The therapeutic exercises will be performed in up to three sets of 8-12 repetitions or 30-60 seconds each, with rest intervals of 90 seconds between sets.
Therapeutic exercise group and pain neuroscience education program
EXPERIMENTALThe therapeutic exercise program will include warm-up, resistance, neuromuscular, mobility, and balance exercises. Over ten weeks, two sessions of the therapeutic exercise program will be carried out individually, lasting approximately 60 minutes each-a total of 20 therapeutic exercise sessions. Therapeutic exercise sessions will be carried out at least 24 hours between sessions. The therapeutic exercises will be performed in up to three sets of 8-12 repetitions or 30-60 seconds each, with rest intervals of 90 seconds between sets. The chronic pain neuroscience education program will be based on three domains. Making sense of pain, exposure with control, and lifestyle changes.
Interventions
The therapeutic exercise program will include warm-up, resistance, neuromuscular, mobility, and balance exercises. Over ten weeks, two sessions of the therapeutic exercise program will be carried out individually, lasting approximately 60 minutes each-a total of 20 therapeutic exercise sessions. Therapeutic exercise sessions will be carried out at least 24 hours between sessions. Therapeutic exercises will be performed in up to three sets of 8-12 repetitions or 30-60 seconds each, with rest intervals of 90 seconds between sets.
In addition to the therapeutic exercise protocol previously reported in the control group, research participants allocated to the experimental group will undergo an education program in the neurosciences of chronic pain carried out one day a week between the two therapeutic exercise sessions lasting ten weeks. The chronic pain neuroscience education program will be based on three domains. Making sense of pain, Exposure with control, and Lifestyle changes also urge modifications aimed at improving sleep, stress, and anxiety.
Eligibility Criteria
You may qualify if:
- A clinical diagnosis of knee osteoarthritis (knee pain for \> 3 months
- Morning stiffness \<30 minutes
- Crepitus
- Bone tenderness, and absence of palpable heat and/or diagnosis established radiographically (determined by Kellgren and Lawrence grade 1 to 3 on a scale 1 up to 4)
You may not qualify if:
- Hip OA
- severe osteoporosis
- Fibromyalgia
- Medical history of tumors or cancer
- Active inflammatory joint diseases (rheumatoid arthritis, gout)
- Undergoing any lower extremity joint replacement
- Neurological diseases (Parkinson's disease, stroke, Multiple Sclerosis, muscular dystrophy, motor neuron disease, Alzheimer's disease, cognitive and cardiopulmonary impairment that may prevent or limit the performance of exercises, use of a gait assistance device, history of recent knee trauma.
- Having undergone any form of treatment involving physiotherapy, intra-articular corticosteroids, anti-inflammatories or chondroprotective in the last six months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nove de Julho University
São Paulo, 01504-001, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cid Gomes, PhD
Nove de Julho University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 15, 2023
First Posted
January 2, 2024
Study Start
May 28, 2024
Primary Completion (Estimated)
November 30, 2026
Study Completion (Estimated)
December 15, 2026
Last Updated
March 20, 2026
Record last verified: 2026-03